Fas signaling-mediated TH9 cell differentiation favors bowel inflammation and antitumor functions
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fas signaling-mediated TH9 cell differentiation favors bowel inflammation and antitumor functions
Authors
Keywords
-
Journal
Nature Communications
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-02
DOI
10.1038/s41467-019-10889-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Features and roles of T helper 9 cells and interleukin 9 in immunological diseases
- (2018) R. Yazdani et al. ALLERGOLOGIA ET IMMUNOPATHOLOGIA
- Th9 Cells Represent a Unique Subset of CD4 + T Cells Endowed with the Ability to Eradicate Advanced Tumors
- (2018) Yong Lu et al. CANCER CELL
- Fas Promotes T Helper 17 Cell Differentiation and Inhibits T Helper 1 Cell Development by Binding and Sequestering Transcription Factor STAT1
- (2018) Gerd Meyer zu Horste et al. IMMUNITY
- STAT3 Activation Impairs the Stability of Th9 Cells
- (2017) Benjamin J. Ulrich et al. JOURNAL OF IMMUNOLOGY
- CD95/Fas, Non-Apoptotic Signaling Pathways, and Kinases
- (2017) Matthieu Le Gallo et al. Frontiers in Immunology
- CD95-Mediated Calcium Signaling Promotes T Helper 17 Trafficking to Inflamed Organs in Lupus-Prone Mice
- (2016) Amanda Poissonnier et al. IMMUNITY
- The transcription factor network in Th9 cells
- (2016) Mark H. Kaplan Seminars in Immunopathology
- The TNF-Family Ligand TL1A and Its Receptor DR3 Promote T Cell–Mediated Allergic Immunopathology by Enhancing Differentiation and Pathogenicity of IL-9–Producing T Cells
- (2015) Arianne C. Richard et al. JOURNAL OF IMMUNOLOGY
- The DNA-binding inhibitor Id3 regulates IL-9 production in CD4+ T cells
- (2015) Hiroko Nakatsukasa et al. NATURE IMMUNOLOGY
- Glucocorticoid-induced tumor necrosis factor receptor–related protein co-stimulation facilitates tumor regression by inducing IL-9–producing helper T cells
- (2015) Il-Kyu Kim et al. NATURE MEDICINE
- The Novel IKK2 Inhibitor LY2409881 Potently Synergizes with Histone Deacetylase Inhibitors in Preclinical Models of Lymphoma through the Downregulation of NF- B
- (2014) C. Deng et al. CLINICAL CANCER RESEARCH
- IL-9 and its receptor are predominantly involved in the pathogenesis of UC
- (2014) Nancy Nalleweg et al. GUT
- The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells
- (2014) Frédérique Végran et al. NATURE IMMUNOLOGY
- Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression
- (2014) Wei Liao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis
- (2013) Kantima Leelahavanichkul et al. Molecular Oncology
- Nuclear Factor of Activated T Cells 1 (NFAT1)-induced Permissive Chromatin Modification Facilitates Nuclear Factor-κB (NF-κB)-mediated Interleukin-9 (IL-9) Transactivation
- (2012) Arijita Jash et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Th9 cells promote antitumor immune responses in vivo
- (2012) Yong Lu et al. JOURNAL OF CLINICAL INVESTIGATION
- OX40 signaling favors the induction of TH9 cells and airway inflammation
- (2012) Xiang Xiao et al. NATURE IMMUNOLOGY
- Robust tumor immunity to melanoma mediated by interleukin-9–producing T cells
- (2012) Rahul Purwar et al. NATURE MEDICINE
- STAT6-Dependent Regulation of Th9 Development
- (2011) R. Goswami et al. JOURNAL OF IMMUNOLOGY
- CD95 triggers Orai1-mediated localized Ca2+ entry, regulates recruitment of protein kinase C (PKC) 2, and prevents death-inducing signaling complex formation
- (2011) N. Khadra et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Modulation of CD4+ T-cell activation by CD95 co-stimulation
- (2010) M Paulsen et al. CELL DEATH AND DIFFERENTIATION
- CD95-Ligand on Peripheral Myeloid Cells Activates Syk Kinase to Trigger Their Recruitment to the Inflammatory Site
- (2010) Elisabeth Letellier et al. IMMUNITY
- Interferon-Regulatory Factor 4 Is Essential for the Developmental Program of T Helper 9 Cells
- (2010) Valérie Staudt et al. IMMUNITY
- The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation
- (2010) Hua-Chen Chang et al. NATURE IMMUNOLOGY
- Effector and Regulatory T-cell Subsets in Autoimmunity and Tissue Inflammation
- (2010) A. Jäger et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Inhibition of the p38 MAP kinase in vivo improves number and functional activity of vasculogenic cells and reduces atherosclerotic disease progression
- (2009) Florian H. Seeger et al. BASIC RESEARCH IN CARDIOLOGY
- Th1, Th17, and Th9 Effector Cells Induce Experimental Autoimmune Encephalomyelitis with Different Pathological Phenotypes
- (2009) A. Jager et al. JOURNAL OF IMMUNOLOGY
- GABA uptake-dependent Ca2+ signaling in developing olfactory bulb astrocytes
- (2009) M. Doengi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Critical role of IL-2 and TGF-β in generation, function and stabilization of Foxp3+CD4+ Treg
- (2008) David A. Horwitz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9–producing subset
- (2008) Marc Veldhoen et al. NATURE IMMUNOLOGY
- IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3− effector T cells
- (2008) Valérie Dardalhon et al. NATURE IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now